FUKUSHIMA Shoji | Department of Pathology, Osaka City University Medical School
スポンサーリンク
概要
関連著者
-
FUKUSHIMA Shoji
Department of Pathology, Osaka City University Medical School
-
WANIBUCHI Hideki
Department of Pathology, Osaka City University Medical School
-
Wanibuchi Hideki
Department Of Pathology Osaka City University Medical School
-
Wanibuchi Hideki
大阪府立成人病センター 分子生物学
-
Takeuchi Yoshikazu
Lab. Of Clinical Pharmaceutics Fac. Of Pharmaceutical Sciences Kobe Gakuin Univ.
-
TAKEUCHI Yoshikazu
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
KISHIMOTO Shuichi
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MORIMURA Keiichirou
Department of Pathology, Osaka City University Medical School
-
Morimura K
Department Of Pathology Osaka City University Medical School
-
Morimura Keiichirou
大阪市立大学 医学部都市医学
-
Morimura Keiichirou
Department Of Pathology Osaka City University Medical School
-
Fukushima S
Japan Bioassay Research Center Japan Industrial Safety And Health Association
-
Fukushima S
Lab. Of Clinical Pharmaceutics Fac. Of Pharmaceutical Sciences Kobe Gakuin Univ.
-
竹内 洋文
50周年誌編集小委員会
-
Wei Min
Department Of Pathology Osaka City University Medical School
-
NOGUCHI Toshihiro
Sumitomo Pharmaceuticals Research Center
-
Wanibuchi Hideki
大阪市立大学 核医
-
Wanibuchi Hideki
Dept. Pathology Osaka City University Medical School
-
OHTANI Aya
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
YAMAOKA Takashi
Sumitomo Pharmaceuticals Research Center
-
WEI Min
Department of Pathology, Osaka City University Medical School
-
竹内 義雄
富山大院医薬
-
YAMAOKA Yumiko
Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University
-
WADA Seiji
Department of Urology, Osaka City University Medical School
-
Wada Seiji
Department Of Urology Osaka City University Medical School
-
Wada Seiji
大阪市立大学 医学部病理学
-
YAMAMOTO Shinji
Department of Neurosurgery, Kyoto Second Red Cross Hospital
-
鈴木 益子
仙台真菌研
-
FUKUDO Hisayuki
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MIYAZAWA Kenji
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
TERAKAWA Yoko
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
ASHIKARI Hiromi
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MITSUHASHI Makoto
Department of Pathology, Osaka City University Medical School
-
Mitsuhashi Makoto
Department Of Pathology Osaka City University Medical School
-
NAKANO Masahiro
Department of Physics, Kyoto University
-
Yamamoto Shinji
Department Of Animal Husbandry Faculty Of Agriculture Tohoku University:(present Address) Department
-
KANG JIN
Department of Pediatrics, The Catholic University of Korea
-
Nakatani Tatsuya
Department of Urology, Osaka City University Medical School
-
MIYAWAKI Kohji
Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University
-
TAGUCHI Kenji
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
SALIM Elsayed
Department of Pathology, Osaka City University Medical School
-
MURAI Takashi
Department of Pathology, Osaka City University Medical School
-
MASUDA Chikayoshi
Department of Urology, Osaka City University Medical School
-
Salim Elsayed
Department Of Pathology Osaka City University Medical School
-
Masuda Chikayoshi
Department Of Urology Osaka City University Medical School
-
Nakatani T
Department Of Urology Osaka City University Medical School
-
Nakatani Tatsuya
大阪市立大学 医学部臓器器官病態外科学
-
Nakatani Tatsuya
大阪市立大学 医研究臓器器官病態外
-
Kang Jin
Department Of Pathology Osaka City University Medical School
-
PUATANACHOKCHAI Rawiwan
Department of Pathology, Osaka City University Medical School
-
Yanai T
Department Of Veterinary Pathology Gifu University
-
Totsuka Yukari
大阪府立大学先端科学イノベーションセンター 遺伝子環境科学研究室
-
Totsuka Y
Cancer Prevention Basic Research Project
-
HAGIWARA Akihiro
DIMS Institute of Medical Science, Inc.
-
NAKAE Dai
Department of Environmental Health and Toxicology, Tokyo Metropolitan Institute of Public Health
-
Yamamoto S
Department Of Pathology Osaka City University Medical School
-
Yamamoto Shinji
大阪市立大学 病理
-
Nakae D
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health:toky
-
TOTSUKA Yukari
Cancer Prevention Division, National Cancer Center Research Institute
-
Hagiwara A
Dims Institute Of Medical Science Inc.
-
Hagiwara Akihiro
Dims医科学研究所
-
Hagiwara Akihiro
大阪市立大学 医学部病理学第1
-
Hagiwara Akihiro
Dims Inst. Medical Sci. Inc.
-
KAWAZOE Yuji
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
KAMIYABU Satoshi
Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University
-
Kakizoe Tadao
Department Of Orthopaedic Surgery Osaka City University Medical School
-
Salim E
Department Of Pathology Osaka City University Medical School
-
Salim Elsayed
大阪市立大学 医学部病理学
-
Kishimoto Taketoshi
Department of Urology Osaka City University Medical School
-
Totsuka Yukari
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Kim Taku
大阪市立大学 泌
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Kitabatake Akira
Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University
-
Nakae D
Department Of Pathology Sasaki Institute Sasaki Foundation
-
Nakae Dai
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Hayashi Yoshie
Department Of Pharmacy Kyoto University Hospital Faculty Of Medicine Kyoto University
-
Hayashi Yoshie
京都大学医学部附属病院 薬剤
-
TATEMATSU Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
KONISHI Yoichi
Department of Oncological Pathology, Cancer Center, Nara Medical University
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Hagiwara Akihiro
Department Pathology Osaka City University Medical School
-
ICHIHARA Toshio
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Ichihara Toshio
Dims医科学研究所
-
Ichihara Toshio
Department Of Pathology Osaka City University Medical School
-
Ichihara T
Department Of Physics Graduate School Of Science Osaka University
-
Ichihara Toshio
大阪市立大学 病理
-
Kitabatake Akira
Department Of Cardiovascular Medicine Hokkaido University School Of Medicine
-
Kitabatake Akira
山口大学 医学系研究科器官病態内科学
-
Takahashi M
National Inst. Health Sci. Tokyo
-
KAMATA Yuri
Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University
-
SUZUKI MASAO
Advanced Science and Technology Research Center, Kyushu University
-
SUZUKI Masao
Oleochemical Research Laboratory, NOF Corporation
-
YASUKAWA Hidehito
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
NAKANISHI Hayao
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
KAKUNI Masakazu
Department of Pathology, Osaka City University Medical School
-
Fukudo Hisayuki
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Akioka Kaname
大阪市立大学 医学部循環器病態内科学
-
KUSHIDA Masahiko
Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, Osaka Prefe
-
Sakuma Ichiro
北海道大学 医学研究科循環病態内科学分野
-
Sakuma I
Graduate School Of Engineering Tokyo University
-
Sakuma Ichiro
Department Of Cardiovascular Medicine Hokkaido University School Of Medicine
-
Sakuma Ichiro
Dept. Of Pharmacology Hokkaido University Graduate School Of Medicine
-
Hayashi S
Department Of Pathology Tokyo Metropolitan Komagome Hospital
-
Horiguchi Shinichiro
鳥取大学 医学部病態解析医学講座医用放射線学
-
高橋 通正
神奈川県環境科セ
-
Kitabatake Akira
北海道大学 大学院医学研究科循環病態内科学
-
HAYASHI Shin-ichi
Saitama Cancer Center Research Institute
-
HAYASHI Shuji
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd.
-
Kitabatake A
山口大学 医学系研究科器官病態内科学
-
Chen Tianxin
大阪市立大学 医学部都市医学
-
Chen T
First Department Of Pathology Osaka City University Medical School
-
Tatematsu Masae
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
小西 陽一
奈良県立医科大学腫瘍病理
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
小西 陽一
奈良医大
-
Tada Mitsuhiro
Division Of Cancer-related Genes Institute For Genetic Medicine Hokkaido University
-
Mori H
Division Of Pathology National Institute Of Health Sciences
-
Yamashita Yasuyuki
Department Of Radiology Kumamoto University
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Inada Ken-ichi
Department Of Pathology Fujita Health University School Of Medicine
-
FURUKAWA Fumio
Division of Pathology, National Institute of Health Sciences
-
TAKAHASHI Satoru
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
MORI Yukio
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
TATEMATSU Kenjiro
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
KOIDE Akihiro
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
FUNAE Yoshihiko
Department of Chemical Biology, Osaka City University Graduate School of Medicine
-
HOSHI Manabu
Department of Orthopedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Researc
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
WAKABAYASHI Keiji
Cancer Prevention Division, National Cancer Center Research Institute
-
IKEHARA Yuzuru
Divisions of Oncological Pathology, Aichi Cancer Center Research Institute
-
UEHARA Nobuaki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
IMAIDA katsumi
Department of Pathology, Nagoya City University Medical School
-
SHIRAI Tomoyuki
Department of Pathology, Nagoya City University Medical School
-
TATEMATSU Masae
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
NAKANISHI Hayao
Laboratory of Pathology, Aichi Cancer Research Institute
-
OKUNO Yasuyoshi
Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd.
-
IMAIDA Katsumi
Onco-Pathology, Faculty of Medicine, Department of Pathology and Host-Defense, Kagawa University
-
KAKIZOE Tadao
National Cancer Center Hospital
-
HAGIWARA Akihiro
Daiyu-kai Institute of Medical Science
-
NOMURA Taisei
Department of Radiation Biology and Medical Genetics, Graduate School of Medicine, Osaka University
-
Imaida K
Onco-pathology Faculty Of Medicine Department Of Pathology And Host-defense Kagawa University
-
Imaida Katsumi
国立がんセンター研究所 がん予防基礎研究プロジェクト
-
Imaida Katsumi
大雄会医科学研究所
-
Imaida Katsumi
Department Of Onco-pathology Faculty Of Medicine Kagawa University
-
Konishi Y
Department Of Oncological Pathology Cancer Center Nara Medical University
-
Konishi Yoichi
奈良県立医科大学附属がんセンター 腫瘍病理学
-
TAKAOKA Kunio
Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine
-
IKENO Mako
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
HORAI Shigeki
Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University
-
TAGUCHI Kenji
Product & Technology Development Laboratory, Tanabe Seiyaku Co., Ltd.,
-
MASAI Hideki
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
TAGUCHI KENJI
Pharmaceutics Division Department, Product & Technology Development Laboratory, Tanabe Seiyaku Co.,
-
KOBAYASHI MASAO
Pharmaceutics Division Department, Product & Technology Development Laboratory, Tanabe Seiyaku Co.,
-
YAMAMOTO Takashi
Sumitomo Pharmaceuticals Research Center
-
KISHIMOTO Syuichi
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
SUZUKI Masao
Olechemical Research Laboratory, NOF corporation
-
VASAVADA RAVINDRA
School of Pharmacy, University of The Pacific
-
津田 喜典
金沢大学薬学部
-
KOIDE Akihiro
Gifu Pharmaceutical University
-
MORI Yukio
Gifu Pharmaceutical University
-
SEKI Shuichi
Department of Hepatology, Graduate School of Medicine, Osaka City University
-
NIWA Toru
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Morimura Keiichiro
Department of Surgery, Osaka City Juso Hospital
-
SENOH Hideki
Department of Pathology, Japan Bioassay Research Center
-
TAKABA Katsumi
Department of Pathology, Osaka City University Medical School
-
NAGANO Kasuke
Department of Pathology, Japan Bioassay Research Center
-
Nakamura Takahiro
Department Of Radiation Biology Graduate School Of Medicine Osaka University
-
Hoshi Manabu
大阪市立大学 医学部病理学
-
Hoshi Manabu
Department Of Pathology Osaka City University Medical School
-
Furukawa F
Division Of Pathology National Institute Of Health Sciences
-
Furukawa Fumio
国立衛生試験所
-
Furukawa Fumio
Division Of Pathology National Institute Of Health Sciences
-
YOSHIMURA Isao
Faculty of Engineering, Tokyo University of Science
-
Mori Yukio
Institute Of Biological Pharmacy Gifu Pharmaceutical University
-
Ikeno Mako
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Inada Ken-ichi
愛知県がんセンター研究所 腫瘍病理学部
-
Kasai Y
Dept Gastroenterological Surgery Nagoya Univ.
-
Kasai Yasushi
名古屋大学 医学部第2内科
-
Ikemoto Shinichi
Department of Urology Osaka City University Medical School
-
Yamamoto Keiswke
Department of Urology Osaka City University Medical School
-
YAMACHIKA Takasuke
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
YASUI Kenzo
Department of Gastroenterological Surgery, Aichi Cancer Center Hospital
-
Morishita Y
First Department Of Pathology Gifu University School Of Medicine
-
Hamada Akinobu
熊本大学医学部附属病院 薬剤
-
Hamada Akinobu
Kumamoto Univ. Hospital Kumamoto Jpn
-
Hamada Akinobu
Department Of Pharmacy Kumamoto University Hospital
-
Kawaguchi Takeo
Department of Cardiology, Odawara Municipal Hospital
-
Kitamura Youji
Department Of Pharmaceutical Sciences Graduate School Of Medicine And Dentistry And Pharmaceutical S
-
Makita Hiroki
岐阜大学 第1病理
-
稲田 健一
Department Of Pathology Fujita Health University School Of Medicine
-
HAGIHARA Atsushi
Department of Pathology, Osaka City University Medical School
-
MIYAZI Natsuko
Department of Pathology, Osaka City University Medical School
-
Yokoi T
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Tsuda Yuko
Faculty Of Pharmaceutical Sciences Kobe Gakuin University:cooperative Research Center Of Life Scienc
-
Wakabayashi Keiji
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Ogawa Motome
大阪市立大学 病理
-
Ogawa Motome
Department Of Pathology Osaka City University Medical School
-
Uehara Nobuaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tagawa Yoshiaki
Drug Developmental Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
著作論文
- Lack of a Dose-response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-Nitrosodiethylamine
- Continuous Exposure to Low-Dose Cisplatin and Apoptosis(Miscellaneous)
- Relation between Intracellular Accumulation and Cytotoxic Activity of cis-[((1Rl,2R)-l,2-Cyclohexanediamine-N,N')bis(myristato)]platinuni(II) Suspended in Lipiodol
- Transdermal Drug Delivery by Electroporation Applied on the Stratum Corneum of Rat Using Stamp-Type Electrode and Frog-Type Electrode in Vitro
- Cytotoxicity of cis-[((1R,2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]-platinum (II) Suspended in Lipiodol in a Newly Established Cisplatin-resistant Rat Hepatoma Cell Line
- Use of Electroporation to Accelerate the Skin Permeability Enhancing Action of Oleic Acid
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- Petroselinic Acid and Oleic Acid : Comparison of Enhanced Skin Permeability Relative to Affinity for Saturated Fatty Acids of Stratum Corneum
- Antitumor Effects of a Novel Lipophilic Platinum Complex (SM-11355) against a Slowly-Groing Rat Hepatic Tumor after Intra-Hepatic Arterial Administration
- Asclepic Acid(cis-ω7-Octadecenoic Acid) as a Skin Penetration Enhancer : Its Behavior and Effects on Rat Stratum Corneum and Dermis
- Enhancement of Propylene Glycol Distribution in the Skin by High Purity cis-Unsaturated Fatty Acids with Different Alkyl Chain Lengths Haiving Different Double Bond Position
- Skin Penetration Enhancing Action of cis-Unsaturated Fatty Acids with ω-9,and ω-12-Chain Lengths
- Enhancement of Propylene Glycol Permeation into Rat Dermis Using High-purity Oleic Acid and Subsequent Alteration of the Dermal Protein Structures
- Absence of β-catenin Mutations in Mouse Hepatoblastomas Induced by N,N-dimethylformamide
- Carcinogenic Potential of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) in Severe Combined Immunodeficient (SCID) Mice
- Lack of Inhibition of BBN-induced Bladder Carcinogenesis in C57BL/6 Mice by Intravesical Instillation of KRN 7000
- P6-02 Enhancement of thioacetamide-induced liver cirrhosis by estradiol 3-benzoate in the rats(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Carcinogenicity of Dimethylarsinic Acid in F344 Rats and p53 (+/-) Knockout and Wild Type C57BL/6J Mice. Relevance with Genetic Alterations and Oxidative DNA Damage (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual
- Establishment and characterization of a human colonic mucinous carcinoma cell line with predominant goblet-cell differentiation from liver metastasis
- Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats
- Differences in Sensitivity of F344 Rats from Different Breeders to Phenobarbital Hepatocarcinogenicity
- Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis
- Histological and Mucin Histochemical Study of Colon Ulcers Induced in Rats by a Rapid Freezing Method
- Di-n-butyl Phthalate is Toxic to the Male Reproductive System and Its Toxicity is Enhanced by Thioacetamide Induced Liver Injury
- Food Restriction Inhibits the Growth of Intestinal Polyps in Multiple Intestinal Neoplasia Mouse
- Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3, 8-dimethylimidazo [4, 5-f] quinoxaline (MeIQx) in rats
- Lack of Promoting Potential of Dimethylarsinic Acid in the Kidney of Male NCI-Black Reiter Rats
- p53 and H-ras Mutations and Microsatellite Instability in Renal Pelvic Carcinomas of NON/Shi Mice Treated with N-Butyl-N-(4-hydroxybutyl)-nitrosamine: Different Genetic Alteration from Urinary Bladder Carcinoma
- p53 in Multiple Human Urothelial Cancers: Assessment for Clonality by the Yeast p53 Functional Assay in Combination with p53 Immunohistochemistry
- Loss of Heterozygosity in (Lewis×F344)F_1 Rat Urinary Bladder Tumors Induced with N-Butyl-N-(4-hydroxybutyl) nitrosamine Followed by Dimethylarsinic Acid or Sodium L-Ascorbate
- Susceptibility of Four F_1 Hybrids of Male Rats to the Promoting Effects of Sodium L-ascorbate in Two-Stage Urinary Bladder Carcinogenesis
- Pharmacokinetics of Ephedrine and Pseudoephedrine after Oral Administration of Kakkonto to Healthy Male Volunteers
- Chemopreventive Effects of Bovine Lactoferrin on N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced Rat Bladder Carcinogenesis
- Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker
- Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf-1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident
- Hormesis in Carcinogenicity of Non-genotoxic Carcinogens
- Aberrant expression of E-cadherin and β-catenin in association with transforming growth factor-β1 in urinary bladder lesions in humans after the Chernobyl accident
- Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol : Evidence for a threshold
- Examination of the Rat Model of Liver Injury via Thioacetamide (TAA) or Carbon Tetrachloride (CCl_4)
- Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine
- Biphasic Increase of Epithelial DNA Synthesis in the Urinary Bladder of Rats Treated with a Tumor Promoter, Sodium L-ascorbate
- Experimental Study of the Relationship between Perfluoro-Octyl Bromide Emulsion and Norepinephrine Release in Reperfusion Arrhythmia : Isolated Guinea Pig Heart Model
- Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation
- Lack of Inhibitory Effects of an Anti-angiogenesis Drug, TNP-470, on Rat Urinary Bladder Papillomatosis Induced by Mechanical Stimulation
- Modulation of the Pharmacokinetics of 5'-Deoxy-5-fluorouridine and 5-Fluorouracil in Rats by Oral Co-administration of Acyclothymidine
- Anticancer Activity of Free γ-Linolenic Acid on AH-109A Rat Hepatoma Cells and the Effect of Serum Albumin on Anticancer Activity of γ-Linolenic Acid in Vitro
- Hydrolysis of 3', 5'-Dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) in Rabbit and Human Plasma and Its Release from Oily Solution
- Lack of Inhibitory Effects of Coumaperine from Pepper on the Promotion Stage of Chemical Hepatocarcinogenesis in the Rat
- Isolation of Differentiated Squamous and Undifferentiated Spindle Carcinoma Cell Lines with Differing Metastatic Potential from a 4-Nitroquinoline N-Oxide-induced Tongue Carcinoma in a F344 Rat
- Inhibitory effect of phenobarbital at low dose on rat hepatocarcinogenesis : the evidence for hormesis (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Thresholds for Carcinogenicity of Environmental Carcinogens (SYMPOSIUM3: RECENT TOPICS ON THE RISK ASSESSMENT OF CHEMICAL CARCINOGENS) (Proceedings of the 30th Annual Meeting)
- Application of liquid chromatography-tandem mass spectrometry for the determination of opioidmimetics in the brain dialysates from rats treated with opioidmimetics intraperitoneally
- Lack of Enhanced Epithelial Cell Proliferation in the Urinary Bladder of Heterozygous p53 Knockout Mice Given Sodium Ortho-phenylphenate or Uracil
- Are tobacco use and urine pH indicated as risk factors for bladder carcinoma?
- PREPARATION AND EVALUATION OF W/O TYPE AND W/O/W TYPE EMULSIONS CONTAINING AN ANTICANCER DRUG
- S4-5 Analysis of Arsenic Carcinogenicity : Using Animal Models(SYMPOSIUM 4: ARSENIC IN THE ENVIRONMENT AND THE TOXICITY)(Proceedings of the 31st Annual Meeting)
- Experimental Studies on Artificial Blood Usage for Hemodilution during Cardiopulmonary Bypass
- Preparation of and Drug Release from W/O/W Type Double Emulsions Containing Anticancer Agents Using an Oily Lymphographic Agent as an Oil Phase(Pharmaceutical)